ArticleACS omega2025
Curing and Degradation Kinetics of Phosphorus-Modified Eugenol-Based Epoxy Resin.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of the Effect of Phosphorus in the Structure of Epoxy Resin Synthesized from Natural Phenol-Eugenol on Thermal Resistance.International journal of molecular sciences · 2025Article
- Flame Retardant from Eugenol as Green Modifier for Epoxy Resins.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Decreasing fossil fuel resources results in a growing demand for polymeric materials obtained from renewable raw materials, such as eugenol. Therefore, this work aimed to assess the kinetics of cross-linking and degradation of epoxy resin obtained from eugenol derivatives and cured with three types of amines: aliphatic: triethylenetetramine (TETA); aromatic: diaminodiphenylmethane (DDM), and cycloaliphatic isophorone diamine (IDA). The product was characterized by
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.